Antidepressant Prescribing Trends in Australia: A Cause for Concern?
A recent study has revealed a concerning trend in Australia's mental health landscape: the long-term use of antidepressants has surged, particularly among young people. The research, conducted by the University of South Australia, analyzed dispensing data from the Pharmaceutical Benefits Scheme (PBS) between 2014 and 2023, covering over 300,000 antidepressant users.
The findings are alarming. In young individuals aged 10-24, the rate of antidepressant use has more than doubled, and a staggering 45% of those on antidepressants are staying on them for over 12 months. Even more concerning, a significant number of young people are still taking these medications after two years.
This trend is not limited to the youth. Long-term antidepressant use has increased across all age groups, but the most dramatic rise is observed in young Australians. This shift in prescribing practices raises critical questions about the potential overprescribing of antidepressants and the adherence to clinical guidelines.
Dr. Lasantha Ranwala, the lead author and a researcher at UniSA, emphasizes the growing concern. "Not only are more people taking antidepressants, but they are staying on them for longer." This is particularly problematic for younger individuals, as clinical guidelines often recommend psychological therapies as the initial treatment of choice.
The study reveals a concerning lack of progress in weaning patients off antidepressants. Despite the increasing long-term use, the proportion of users who were put on a lower dose remained constant over the decade, at 17.9% in 2014 and 17.8% in 2023. This indicates that deprescribing strategies are not being consistently implemented in clinical practice.
Several factors contribute to this trend, including a rise in mental health issues among young people, increasing rates of psychological distress, the impact of the COVID-19 pandemic, and limited access to psychological therapies. With mental health demands at an all-time high, the authors advocate for a balanced approach, ensuring appropriate use of antidepressants and adequate support for patients to reduce or discontinue treatment when necessary.
Prof. Libby Roughead, a co-author and Director of the Quality Use of Medicines and Pharmacy Research Centre, emphasizes the need for a stronger framework for safely tapering antidepressants and improved access to psychological care. Emerging technologies, such as predictive analytics and clinical decision-support tools, may also assist clinicians in identifying when deprescribing is appropriate.
The study, 'Increasing Prevalence of Long-Term Antidepressant Use in Australia,' published in Pharmacoepidemiology and Drug Safety, highlights the urgent need for action to address this growing concern in Australia's mental health system.
